Compounds > 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone
Page last updated: 2024-09-03

2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone and Lung Neoplasms

2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arthurs, CL; Stratford, IJ; Whitehead, RC; Wind, NS1

Other Studies

1 other study(ies) available for 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone and Lung Neoplasms

ArticleYear
Analogues of 2-crotonyloxymethyl-(4R,5R,6R)-4,5,6-trihydroxycyclohex-2-enone (COTC) with anti-tumor properties.
    Bioorganic & medicinal chemistry letters, 2007, Jan-15, Volume: 17, Issue:2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclohexanones; Drug Design; Glutathione; Humans; Indicators and Reagents; Lung Neoplasms

2007